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Sustained intracellular acidosisThe mammalian Na+/H+ exchanger isoform 1 (NHE1) is a ubiquitously expressed pH-regulatory membrane
protein that functions in the myocardium and other tissues. It is an important mediator of the myocardial
damage that occurs after ischemia–reperfusion injury and is implicated in heart hypertrophy. Regulation of
NHE1 has been proposed as a therapeutic target for cardioprotection. We therefore examined mechanisms of
control of NHE1 in the myocardium. Several different amino acids have been implicated as a being critical to
NHE1 regulation in a number of tissues including Ser703, Ser770, and Ser771. In the myocardium, NHE1 is
activated in response to a variety of stimuli including activation by an ERK-dependent sustained intracellular
acidosis. In this study, we determined whether Ser703 and p90rsk activity are critical in activation of NHE1 by
sustained intracellular acidosis. In vitro phosphorylation of NHE1 C-terminal fusion proteins determined that
ERK-dependent phosphorylation of the cytoplasmic region was not dependent on Ser703; however,
phosphorylation by p90rsk required Ser703. A Ser703Ala mutation decreased basal NHE1 activity in CHO cells
but not in cardiomyocytes. NHE1 with a Ser703Ala mutation was activated in response to sustained
intracellular acidosis in CHO cells. In addition, sustained intracellular acidosis also activated the Ser703Ala
mutant protein in isolated cardiomyocytes and phosphorylation levels were also increased by acidosis. The
presence of a dominant-negative p90rsk kinase also did not prevent activation and phosphorylation of NHE1
by sustained intracellular acidosis in isolated cardiomyocytes. We conclude that Ser703 and p90rsk are not
required for activation by sustained intracellular acidosis and that p90rsk phosphorylation of Ser703 is
independent of this type of activation.extracellular signal-regulated
3β, glycogen synthase kinase-
; SIA, sustained intracellular
+1 780 492 0886.
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The Na+/H+ exchanger isoform-1 (NHE1) is a plasma membrane
glycoprotein that protects cells from intracellular acidiﬁcation by
removing one intracellular proton in exchange for one extracellular
sodium ion [1]. There are 10 isoforms of Na+/H+ exchanger (NHE1–
NHE10), and the ﬁrst isoform discovered (NHE1) is the only type that
is ubiquitously distributed [2,3]. NHE1 also plays important roles in
cell volume regulation, cell differentiation, and proliferation and in
growth of some tumor cells [1,4,5]. The NHE1 isoform is critical in the
myocardium in mediating the damage that occurs with myocardial
ischemia/reperfusion injury [6,7] and is an important mediator of
heart hypertrophy [8]. Chronic inhibition of NHE1 attenuates
development of cardiac hypertrophy and can cause regression of
cardiac hypertrophy [9].NHE1 levels and activity are elevated in several models of heart
disease [10,11]. NHE1 activity is also elevated in patients with end-
stage heart failure [12]. We demonstrated that protein kinases that
regulate NHE1 activity are activated in the myocardium by ischemia
and reperfusion of intact hearts or isolated cardiomyocytes [13]. In
addition, NHE1 is activated by sustained intracellular acidosis (SIA)
[14,15]. To delineate which amino acids are critical for activation of
NHE1, we earlier made mutations of NHE1 proteins and found that
amino acids Ser770 and Ser771 are required for activation of NHE1 by
sustained acidosis in CHO cells [15] and in isolated cardiomyocytes
[16]. However, a number of studies have implicated Ser703 as being
critical to NHE1 function. Takahashi et al. [17] demonstrated the
importance of Ser703 in p90rsk-dependent activation of NHE1 by
growth factors in 293 cells. Furthermore, phosphorylated Ser703 was
shown to be important in binding of the adaptor protein 14-3-3 to
NHE1, and mutation Ser703Ala abolished this binding [18,19].
While extensive preclinical work has indicated that inhibition of
the Na+/H+ exchanger affords signiﬁcant protection to the myocar-
dium subjected to ischemia and reperfusion, this has been contrasted
by clinical studies that have given largely poor results when using
NHE1 inhibitors. It has recently been suggested that the NHE kinase
RSK might be an appropriate therapeutic target for indirectly
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further investigated [20]. Therefore, in this study, we examined the
importanceof Ser703 and thep90rsk pathway in the activation ofNHE1 in
the myocardium. Several pathways of activation of NHE1 by different
stimuli such as hormones and apoptosis stimulate NHE1. These stimuli
have been suggested to act through phosphorylation of different amino
acids to activate NHE1 in different cell types [17,21,22]. Stimulation of
NHE1 activity and NHE1-directed protein kinases by ischemia and
chronic acidosis may be important in NHE1-mediated damage in the
cardiovascular system [13,23]. Chronic acidosis is an important clinical
problem in many diseases and notably occurs quickly and persistently
after coronary artery occlusion in the myocardium [24]. We therefore
studied activation of NHE1 by sustained intracellular acidosis (SIA) in
isolated cardiomyocytes [14,15]. Our results suggest that Ser703 and
p90rsk are not essential for the activation of NHE1 by SIA in isolated
cardiacmyocytes and CHO cells. These suggest that acute acidosis could
still activate the NHE1 protein in the clinical setting, independent of
blockade of p90rsk activity.
2. Materials and methods
2.1. Materials
Routine chemicalswere of analytical grade andwerepurchased from
BDH (Toronto, ON), Fisher Scientiﬁc (Ottawa, ON), or Sigma (St. Louis,
MO, USA). Other chemicals were collagenase type 2 (Worthington
Biochemical Corporation (Lakewood, NJ)) and BCECF-AM (2′,7-bis(2-
carboxyethyl)-5(6) carboxyﬂuorescein-AM) from Molecular Probes
(Eugene, OR, USA). Also, platinum R Taq Polymerase was from
Invitrogen (Burlington, Ontario, Canada), and EMD87580 was a
generous gift of Dr. N. Beier of Merck KGaA, Frankfurter, Germany.
PWO DNA polymerase was obtained from Roche Applied Science, and
Lipofectamine™ 2000 reagent was from Invitrogen Life Technologies
(Carlsbad, CA, USA). Mouse anti-NHE1 antibody was from BD
Biosciences (San Jose, CA, USA). The monoclonal antibody for alpha-
myosin heavy chain (MF20) was from the Developmental Studies
HybridomaBankof theUniversity of Iowa, (IowaCity, IA). Anti-phospho
glycogen synthase kinase-3beta (GSK3β) and anti-p90rsk antibodywere
from Cell Signaling Technology (Beverly,MA, USA). Anti-hemagglutinin
(HA) antibodyY-11was fromSanta Cruz Biotechnology (Santa Cruz, CA,
USA). Protein-A sepharose beads were from Sigma (St. Louis, MO, USA),
and [32P]orthophosphate was from Perkin Elmer Life and Analytical
Sciences (Boston, MA, USA).
2.2. Exchanger fusion proteins
The carboxyl-terminal 178 aminoacids of the rabbit cardiacNa+/H+
exchanger (amino acids 639–816) were expressed as described
previously [25] as a fusion protein with GST (Gst178) using the plasmid
pGEX-3X. The Escherichia coli TOPP 2 strain was induced with 1 mM
isopropylthio-β-D-galactoside. GST-Na+/H+ exchanger fusion protein
was puriﬁed via glutathione Sepharose 4B afﬁnity chromatography as
describedearlier [13]. A series of related fusionproteinsofGSTwere also
made and puriﬁed using the same procedures. Gst703 was the same as
Gst178 but with amino acid Ser703 mutated to alanine. Δ662–794 had
amino acids 662 to 794 deleted from Gst178. Gst702 was the same as
Gst178 but terminated at amino acid 702. For some experiments, we
expressed and puriﬁed the C-terminal 182 amino acids of NHE1 as a
fusionproteinwith ahistidine tag (as opposed to aGST tag). This protein
was produced and puriﬁed as described earlier [26].
2.3. Preparation of cell extracts of isolated myocytes and in-gel kinase
assays
Tissue extracts were made from isolated perfused hearts or
isolated myocytes essentially as described earlier [13,25]. Heart tissuewas homogenized at a high setting with a Polytron homogenizer for
30 s in 2.5% (vol./wt.) of extraction buffer containing 50 mM tetra-
sodium pyrophosphate, 50 mM sodium ﬂuoride, 50 mM sodium
chloride, 5 mM ethylene-diaminetetra-acetic acid disodium salt
(EDTA), 5 mM ethylene glycol-bis (β-aminoethyl ether) N,N,N,N′-
tetraacetic acid (EGTA), 0.1 mM sodium orthovanadate, 0.1% Triton X-
100, 10 mM HEPES pH 7.4, and a cocktail of protease inhibitors. The
homogenate was centrifuged at 6000 g × 60 min at 4 °C. To identify
protein kinases that phosphorylated the Na+/H+ exchanger fusion
proteins, cell extracts (80 μg protein) from isolated myocytes or
isolated perfused hearts were prepared and run on 10% SDS–PAGE in a
gel containing 1 mg/mL of substrate. In-gel kinase assays were
performed as previously described [25]. The gels were dried for
autoradiography and visualization of phosphorylation. Protein con-
centrations were measured using the Bio-Rad DC protein assay.
2.4. In vitro phosphorylation of the Na+/H+ exchanger fusion proteins
The standard reaction conditions for phosphorylation of heart
extract fractions contained 3.0–8.0 μg of substrate, 8 μl of heart
extract, 12.5 mM 3-(4-morpholino) propane sulfonic acid (MOPS) pH
7.2, 0.5 mM EGTA, 2 mM DTT and 8.5 mM magnesium chloride, 6 μM
okadaic acid, 0.24 mM sodium ﬂuoride, 500 μM ATP, and 1 μl of
10 μCi/μl of [γ-32P]ATP (3000 Ci/mmol) in a ﬁnal volume of 24 μl
(modiﬁed after Moor and Fliegel [25]). Samples were incubated at
30 °C for 90 min, and the reaction was terminated by the addition of
SDS loading buffer. Samples were run on a 12% SDS gel, dried, and
exposed for autoradiography. The appropriate bands were identiﬁed
by autoradiography. For some experiments, we used immunopreci-
pitated ERK or p90rsk kinase to phosphorylate the Na+/H+ exchanger
fusion proteins. This was prepared with commercial antibody as
described earlier [13]. For other experiments, we used commercially
available active ERK2 to phosphorylate Na+/H+ exchanger fusion
proteins (Cell Signaling Technologies, Danvers, MA, USA). The
reaction contained 0.38 ng of ERK2 in a buffer as described above.
2.5. Western blotting and immunoprecipitation
SDS–PAGE and immunoblotting were performed essentially as
described earlier [27]. For Western blot analysis, equal amounts of up
to 100 μg of each sample were resolved on 10% SDS/polyacrylamide
gels. Nitrocellulose transfers were immunostained using anti-HA
monoclonal antibody for NHE1 detection (Boehringer Mannheim,
Laval, Quebec, Canada) or anti-NHE1 monoclonal antibody (BD
Biosciences). Second antibody was peroxidase-conjugated goat anti-
mouse antibody (Bio/Can, Mississauga, Ontario, Canada) and visual-
ized using a chemiluminescence detection system. To visualize and
quantify immunoreactive proteins, we used a Li-COR ﬂuorescence
labeling and detection systems (LI-COR Biosciences, Lincoln, NE, USA).
2.6. Site-speciﬁc mutagenesis
Site-speciﬁc mutagenesis of Ser703 to Ala was as described earlier
[28]. The primers used were 5′-GGCCCGCATCGGCgCgGAtCCACTGGCC-
TATGAG-3′ (forward) and 5′- CTCATAGGCCAGTGGaTCcGcGCC-
GATGCGGGCC-3′ (reverse). The mutated nucleotides are in lower case
letters and bold. The new restriction site BamHI was created by silent
mutation. The mutated hemagglutinin (HA)-tagged NHE1 cDNA was
transferred to pAdTrack-CMV, and the virus was produced using the
pAdEasy system as described earlier [16]. DNA sequencing conﬁrmed
the mutation and ﬁdelity of the cDNA after mutation.
2.7. Cell culture and stable transfection
Stable cell lines expressing the wild type HA-tagged NHE1 protein
and the mutant NHE1 with a Ser703Ala mutation were made in AP-1
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a Chinese hamster ovary cell line that lacks an endogenous Na+/H+
exchanger. Brieﬂy, the cells were grown in a humidiﬁed atmosphere
of 5% CO2 and 95% air in α-MEM supplemented with 10% (vol./vol.)
bovine growth serum, 25 mM HEPES, penicillin (100 U/mL), and
streptomycin (100 μg/mL), pH 7.4 at 37 °C. Transfection was with
LIPOFECTAMINE™ 2000 reagent, and selection of stable cell lines was
carried out with 800 μg/mL G418 as described previously [29]. After
initial selection, single clones of transfected cells were obtained, and
stable cell lines were maintained in 400 μg/mL G418 and were
regularly reestablished from frozen stocks at passage numbers
between 5 and 15 where necessary. Cell lysates from AP-1 cells
were made as described earlier [29].
2.8. Preparation and treatment of isolated cardiomyocytes
Five- to six-day-old neonatal Sprague-Dawley rat heart ventricles
were used to prepare primary cultures of cardiomyocytes as described
earlier [25]. Isolated primary cardiomyocytes were plated onto
Corning culture dishes or ﬂasks when harvesting cell extracts or
onto glass coverslips for intracellular pH measurements. Myocytes
were maintained for 48 hours before adenoviral infection in a
medium containing Dulbecco's modiﬁed Eagle's medium supplemen-
ted with 10% bovine growth serum (FBS), 10 μg/mL transferrin,
10 μg/mL insulin, 10 ng/mL selenium, 50 U/mL penicillin, 50 μg/mL
streptomycin, 2 mg/mL bovine serum albumin (BSA), 5 μg/mL
linoleic acid, 3 mM pyruvic acid, 0.1 mM minimum essential medium
(MEM) nonessential amino acids, 10% MEM vitamin, 0.1 mM
bromodeoxyuridine, and 30 mM HEPES, pH 7.4.
When indicated, isolated cardiomyocytes were infected with
adenovirus containing HA-tagged NHE1 gene. The basis of the
adenoviral constructs (pADTRack-CMV-NHE1) was described earlier
[16,30], and they contain full-length cDNA of a hemagglutinin (HA)-
tagged NHE1 isoform of the Na+/H+ exchanger. The NHE1 cDNA
expression contains a double-mutation Leu163Phe/Gly174Ser that
increases the resistance to inhibition by EMD87580 and other NHE1
inhibitors [16,30]. This allows detection of its activity while inhibiting
the endogenous NHE1 protein activity with EMD87580. Infection by
adenovirus was routinely monitored by GFP expression, and more
than 99% of cells were infected. Control cells were infected with an
adenovirus that expressed GFP alone. Cells were routinely infected at
a multiplicity of infection of 20 (PFU/cell). Control or experimental
adenoviruses were maintained on cells for a period of 24 hours before
characterization of activity. The S770/771A adenovirus contains the
inhibitor-resistant NHE1 with the mutations of Ser770 and Ser771 to
Ala as described earlier [16,30].
2.9. Intracellular pH measurement
Intracellular pH measurement in AP-1 cells was as described
earlier using monolayers of coverslips of cells loaded with BCECF-AM
[15]. NHE1 activity was examined in isolated cardiomyocytes that
were mock-infected and infected with pAd-NHE1 or pAd-GFP (which
is a control adenovirus expressing only GFP) as described earlier [16].
Cells were infected for approximately 24 hours before intracellular pH
measurement. Isolated cardiomyocytes were grown on coverslips,
and pH changes were measured using a PTI Deltascan spectroﬂuo-
rometer. Coverslips were held in a holder that was preciselymachined
to ﬁt cuvettes and retain coverslips. Solutions were changed rapidly
by removing coverslips in the holder from one solution and placing
them in a new solution. All solutions were at 37 °C and were stirred
constantly during pH measurement. The initial rate of recovery was
measured during the ﬁrst 20 s after return of NaCl at 37 °C. A
calibration curve was done with nigericin at the end of every
experiment to calibrate intracellular pH to ﬂuorescence as described
earlier [28]. To examine NHE1 activity in isolated cardiomyocytes inresponse to SIA, we used an assay we have recently described [15,16].
Brieﬂy, cells were treated with ammonium chloride two times, and
allowed to recover in NaCl containing medium after each treatment.
After the ﬁrst treatment with ammonium chloride, cells were rinsed
with Na+-free medium for 10–20 s and then the decline in pHi was
allowed to stabilize. After the pHi was no longer declining and
stabilized, NaCl was added to allow for intracellular pH recovery. The
second pulse was done similarly except cells weremaintained in Na+-
free medium for 3 min before reintroduction of 135 mMNaCl to cause
SIA. Where appropriate, the value obtained for the second pulse in the
presence of SIA was compared to that obtained for a second pulse in
the absence of SIA. This activity, in the absence of SIA, was referred to
as basal NHE1 activity. For experiments with cells infected with
adenovirus, in some cases, assays were done in the presence of 10 μM
EMD87580where indicated. This inhibited N95% of endogenous NHE1
but did not inhibit the exogenously expressed NHE1 because it
contained two mutations (Leu163Phe/Gly174Ser) that made it
resistant to inhibition [16]. All results are shown as the mean±SE
and statistical signiﬁcance was determined using the Wilcoxon–
Mann–Whitney rank-sum test.
2.10. Immunoprecipitation of phospho-NHE1 protein
Cell lysates from isolated cardiomyocytes incubated with [32P]
were used for the immunoprecipitation of exogenously expressed
NHE1. The procedure was as essentially described earlier and
exogenous NHE1 was immunoprecipitated using the HA tag [13].
RIPA buffer contained 50 mMTris (pH 8.0), 150 mMNaCl, 80 mMNaF,
5 mM EDTA, 1 mM EGTA, 25 mM Na-pyrophosphate, 1 mM Na-
orthovandate, and protease inhibitors (0.1 mM phenylmethylsulfonyl
ﬂuoride, 0.1 mM benzamidine, 40 μM ALLN) plus detergents at
concentrations of 1% NP-40, 0.1% SDS, and 0.05% deoxycholate. After
incubating in [32P]-containing medium, cells were washed in
phosphate-free buffer and treated with ammonium chloride to induce
SIA as described above. Ice-cold RIPA buffer (3 mL without deter-
gents) was added, and cells were placed on dry ice to freeze them.
After thawing on wet ice, cells were scraped into centrifuge tubes and
sonicated for 10 s. Cells were centrifuged at 35,000 rpm×1 hour and
1 mL of RIPA buffer with detergents was added to the pellet to
solubilize NHE1. After 15 s of further sonication, the sample was
centrifuged at 10,000 rpm×30 min, and the supernatant was used for
immunoprecipitation of NHE1 via the HA tag as described earlier [16].
After SDS–PAGE, samples were transferred to nitrocellulose mem-
branes, and radioactivity was detected by using a Typhoon 9400,
Variable Mode Imager (GE Healthcare, Piscataway, NJ). Immunoblot-
ting with anti-HA antibody was routinely used to check the level of
NHE1 in the samples and correct for any variation in immunoprecip-
itation efﬁciency. Quantiﬁcation was done with the Odyssey scanning
system (LI-COR Biosciences, USA). Results are the mean±SE of at
least three experiments.
3. Results
3.1. Phosphorylation of NHE1 by heart extracts
We have previously demonstrated that ERK is involved in the
regulation of NHE1 in the myocardium and that ERK can directly
phosphorylate a fusion protein containing the C-terminal region of
NHE1 [13,25]. Initial experiments were to conﬁrm this observation
and to delineate which amino acids are critical for regulation of NHE1
via phosphorylation by ERK. For this purpose, we made a number of
fusion proteins of the C-terminus of the protein (Fig. 1). In-gel kinase
assays [25] were initially done with heart cell extracts to make a gross
assessment of the regions of the NHE1 C-terminus that heart cell
extracts can phosphorylate. The results are shown in Fig. 2. In-gel
kinase assays of heart extracts with the C-terminal 178 amino acids of
Fig. 1. (A) Amino acid sequence of C-terminal amino acids 639–816 of rabbit NHE1.
Ser703 is underlined. (B) Mutant NHE1 fusion proteins used in this study. GST,
glutathione S-transferase; His, histidine tag. Numbers indicate amino acid numbers of
the NHE1 protein.
Fig. 2. Na+/H+ exchanger-directed protein kinase activity of heart extracts using
Gst178 or Δ662–794 as a substrate. The schematic diagram below each gel indicates the
substrate used for the in-gel kinase assay. Heart extracts were used for in-gel kinase
assay as described in Materials and methods. Lanes 1 and 2 are duplicate myocyte
extracts run in a gel using the Na+/H+ exchanger fusion protein as a substrate (1 mg/mL)
(Gst178). It contains the terminal 178 amino acids of the rabbit NHE1 protein. Lanes 3 and
4were the same cell extracts from hearts that used for in-gel kinase assays containing the
same region of the Na+/H+ exchanger except that amino acids 662 to 794 were deleted
(Δ662–794).
Fig. 3. Phosphorylation of the Na+/H+ exchanger by heart cell extracts and immunopre-
cipitated ERK1/2. (A) Cell extracts from intact hearts were incubated with Na+/H+
exchanger fusion proteins in a buffer containing [γ32P]ATP as described in Materials and
methods. Lane 1 is a control reactionwith no Na+/H+ exchanger fusion protein. Lane 2 is a
reaction containing cell extracts and GST–Na+/H+ exchanger fusion protein containing the
C-terminal 178 amino acids of the protein. Lane 3 is a reaction with cell extracts and His-
tagged Na+/H+ exchanger containing the C-terminal 182 amino acids of the Na+/H+
exchanger. * and# indicate theposition of the full-lengthGST andhistidine-taggedNa+/H+
exchanger fusion proteins respectively. (B) Phosphorylation of the Na+/H+ exchanger by
immunoprecipitated ERK1/2. ERK1/2was immunoprecipitated from intact hearts and used
to phosphorylate Na+/H+ exchanger fusion proteins as described in the Materials and
methods. Lane 1 is a control reactionwith no Na+/H+ exchanger fusion protein. Lane 2 is a
reaction containing cell extracts and as in A and His182 (His-tagged Na+/H+ exchanger
with the C-terminal 182 amino acids of the Na+/H+ exchanger). Lane 3 is a reaction with
ERK1/2 immunoprecipitated from heart cell extracts phosphorylating GST–Na+/H+
exchanger fusion protein containing the C-terminal 178 amino acids of the protein
(Gst178). Lane 4 is a similar reaction to lane 3, except containing His182 and
immunoprecipitated ERK1/2.
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the NHE1 protein (lanes 1 and 2). A prominent kinase was of mole-
cular weight of approximately 44 kDa, the same size as ERK. A
duplicate experiment also used heart extracts to phosphorylate the
NHE1 C-terminus (lanes 3 and 4) except that it used a fusion protein
(Δ662–794) that had amino acids 662–794 deleted. While some
kinases were still active toward this fusion protein, there was a very
noticeable absence of kinase activity in the 44-kDa range. In-gel
kinase assays with either the entire C-terminus or with Δ662–794 did
not show strong phosphorylation in the 90-kDa region.
3.2. Localization of NHE1 phosphorylation sites
To localize the region of the Na+/H+ exchanger that was
phosphorylated by ERK we used in vitro phosphorylation of Na+/H+
exchanger proteins expressed and puriﬁed from E. coli. In initial
experiments, we used awhole heart extract and examined the ability of
the extract to phosphorylate either a GST fusion of the C-terminal 178
amino acids of the Na+/H+ exchanger or a histidine-tagged fusion of
the C-terminal 182 amino acids of the Na+/H+ exchanger. Lane 1
(Fig. 3A) is a control showing that, under the conditions used, without
the presence of a substrate, little autophosphorylation of the cell extract
occurred. Lanes 2 and 3 show that cell extracts phosphorylate the Na+/
H+ exchanger–GST and Na+/H+ exchanger–His-tagged (His182)
fusion proteins that contain the C-terminal of the Na+/H+ exchanger.
We then used immunoprecipitated ERK1/2 fromheart cell extracts
to examine if this kinase could directly phosphorylate the Na+/H+
exchanger fusion proteins. Fig. 3B shows the results. Lane 1 is a control
without any substrate added to the in vitro phosphorylation reaction.
There was no evidence of autophosphorylation of the immunoprecip-
itate. Lane 2 is a second control whereby we used the whole extract ofintact hearts to phosphorylate the His182 fusion protein. Lane 3 shows
that immunoprecipitated ERK1/2 could phosphorylate the GST-
tagged fusion protein of the Na+/H+ exchanger. Lane 4 shows that
the histidine-tagged fusion protein (not containing GST) is also
phosphorylated by immunoprecipitated ERK1/2.
To determine whether Ser703 could be phosphorylated by ERK or
p90rsk, we made a series of fusion proteins that contained truncations,
mutation, or deletions of the Na+/H+ exchanger C-terminus.We then
used these proteins as a substrate of commercially available ERK2 or
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kinase was used as a source rather than immunoprecipitated ERK
from the myocardium because it was possible to obtain larger
amounts of the kinase that gave consistent results. The effect of
these mutations and deletions is shown in Fig. 4. ERK kinase (Fig. 4A)
phosphorylated Gst178 and Gst703 (which had amino acid 703
mutated to alanine). In contrast, there was no phosphorylation of
Δ662–794 or Gst702. Another similar experiment showed that the
His182 fusion protein (C-terminal 182 of NHE1 with histidine tag)
was also phosphorylated by ERK2, while additionally, another
histidine-tagged fusion protein with amino acids 639 to 763 deleted
was phosphorylated to an equal or greater extent (not shown). Fig. 4B
shows that p90rsk phosphorylated the Gst178 (lane 1) protein, but
this phosphorylation was almost eliminated (10%–15%) by mutation
of Ser703 to alanine (lane 2). In addition, Δ662–794 and Gst702 were
not phosphorylated by p90rsk. These experiments showed that amino
acid Ser703 was not critical for the phosphorylation of the NHE1 C-
terminus by ERK in vitro; however, in vitro phosphorylation by p90rsk
was virtually eliminated by mutation or deletion of Ser703.
3.3. Effect of Ser703 mutation on NHE1 activity in AP-1 cells
To characterize the role of Ser703 in the ability of NHE1 to be
activated by SIA, we mutated this residue to Ala and examined the
effects on activation of NHE1 by SIA in AP-1 cells. AP-1 cells are a CHO
cell line with the endogenous NHE1 protein absent [29]. Fig. 5A
conﬁrms that we stably expressed the NHE1 protein in these cells.
Western blotting demonstrates that both the fully glycosylated and
the partially or deglycosylated form of the protein were present,
similar to earlier results [15,29]. Partially or deglycosylated NHE1
represents mostly intracellular protein [15,29].
To characterize the activity of the NHE1 protein in response to SIA,
we used a two-pulse assay [15]. Cells were given two ammonium
chloride pulses. After the ﬁrst ammonium chloride treatment, cells are
allowed to recover immediately. After the second ammonium chloride
treatment, cells are maintained in sodium free medium for 3 min to
create a sustained acidosis. This stimulates NHE1 activity. The second
pulse of SIA can be maintained by either sodium-free medium or
alternatively, sodium-containing medium in the presence of NHE1
inhibitor [16]. In a separate two-pulse assay, a second pulse without a
sustained acidosis is used as a control. Examples of the effects of SIA
on control and Ser703Ala mutant NHE1 protein are shown in Figs. 5B–
E. For clarity, only the second pulses are shown. With two ammonium
chloride pulses without SIA, the second recovery was equivalent to
the ﬁrst (Fig. 5B). With SIA, the activity of NHE1 after the second pulse
was increased (Fig. 5C). Figs. 5D and E show that the sameFig. 4. Phosphorylation of various fusionproteins of theNa+/H+exchanger by the protein
kinases ERK2 and p90rsk. A series of GST fusions of the Na+/H+ exchangerweremade and
used for in vitro phosphorylation as described in Fig. 3. The fusion proteins used were as
follows: lane 1, Gst178 (GST and amino acids 639–816); lane 2, Gst703, C-terminal 178
amino acids but with serine 703 mutated to alanine; lane 3, Δ662–794 same protein as
lane 1 except amino acids 661–794 were deleted; lane 4, Gst702, GST fusion expressing
amino acids 639–702. (A) ERK2 was used to test if a variety of Na+/H+ exchanger fusion
proteinswere susceptible to in vitro phosphorylation. (B) Immunoprecipitated p90rsk was
used for in vitro phosphorylation of the same samples as in A.phenomenon occurred with the Ser703Ala mutant NHE1 protein.
SIA stimulated the second recovery from SIA (Fig. 5E). A summary of
these results is shown in Fig. 5F. For cells with wild type NHE1 treated
without SIA, the activity after the second pulse was not changed
signiﬁcantly. When treated with SIA, the wild type NHE1 activity after
the second pulse was greatly and signiﬁcantly increased. This is
consistent with our previous results [15]. Interestingly, similar results
were found with the Ser703Ala mutant, and the activity with SIA was
also signiﬁcantly elevated (Fig. 5F). The absolute level of activity of the
wild type NHE1 protein was 1.08±0.018 ΔpH/min. The level of
activity of the Ser703Ala mutant was reduced about 25% in
comparison to the wild type to a value of 0.85±0.036 ΔpH/min.
Overall, these results show that the Ser703Ala mutant NHE1 protein,
while slightly reduced in activity, was still signiﬁcantly activated by
SIA in AP1 cells in the same manner as controls.
3.4. Expression of exogenous NHE1 in cardiomyocytes
To examine the importance of Ser703 and p90rsk in isolated
cardiomyocytes, we expressed the mutated NHE1 protein in isolated
cardiomyocytes. Because isolated cardiomyocytes have their ownNHE1
protein, we inhibit the endogenous NHE1 protein with an NHE1
inhibitor. We express an “exogenous” NHE1 protein that has an HA tag
for detection and mutations that leave it functional, but resistant to
NHE1 inhibitors (Leu163Phe and Gly174Ser) [16]. Either a wild type
exogenous NHE1 protein was expressed, or one which had Ser703
changed to alanine. Fig. 6A shows a Western blot of isolated
cardiomyocytes that had been infected with HA-tagged NHE1 proteins.
Both the wild type NHE1 and Ser703Ala mutant expressed NHE1 to
similar levels in isolated cardiomyocytes. GFP-infected cells had only a
slight background staining that was often present with the anti-HA
antibody used. Probing with anti-myosin heavy chain antibody (MF20,
lower panel) conﬁrmed that equal amounts of sample were present on
the blot.
To further conﬁrm that we had expressed NHE1 protein, we used
an antibody against NHE1 (as opposed to the NHE1 HA tag). The
results (Fig. 6B) show that the wild type adenovirus and the
Ser703Ala mutant both increased the level of expression of NHE1 in
isolated cardiomyocytes (lanes 4 and 5). AP-1 cells transfected with
wild type NHE1 plasmid were used as a positive control (lane 1).
3.5. Expression of dominant-negative p90rsk in cardiomyocytes
We used a p90rsk dominant-negative adenovirus that expresses an
HA-tagged p90rsk protein with a mutation at Lys100Ala, which
renders it catalytically inactive (a gift from Dr. M. Avkiran, St. Thomas
Hospital, London). To characterize this virus, we infected cells and
examined expression of the resultant protein. Western blotting using
anti-HA antibody (Fig. 6C) showed that infection with this virus
produced the resultant tagged protein. Uninfected cells only showed a
nonspeciﬁc background staining that was present with this antibody.
We conﬁrmed that exogenous p90rsk protein was expressed using
an antibody against the p90rsk protein itself (Fig. 6D). Immunoblotting
GFP-infected cells (lane 1) showed the characteristic double band of
p90rsk (indicated by the asterisk), while cells infected with the
dominant-negative p90rsk showed an increased amount of slightly
larger protein (its increased size likely due to the HA tag).
To conﬁrm that the dominant-negative p90rsk adenovirus was
functioning appropriately, we used Western blotting against phos-
phorylated GSK3β (Ser9). In experiments similar to those done by
others, we examined the effectiveness of phorbol 12-myristate 13-
acetate (PMA)-induced phosphorylation which is mediated by RSK
[31]. The results are shown in Figs. 7A and B. Stimulation of either
mock- or GFP-infected cells resulted in increased levels of phosphor-
ylation of GSK3β. However, when cells were treated with dominant-
negative p90rsk, there was no increase in GSK3β phosphorylation with
Fig. 5. Analysis of wild type andmutant (Ser703Ala) NHE1 protein in AP-1 cells. (A)Western blot analysis (anti-HA antibody) of NHE1 expression in stable cell lines transfected with
pYN4+ plasmid expressing NHE1 protein. Wt, cells transfected with wild type NHE1 protein; 703, cells transfected with NHE1 containing the Ser703Ala mutation. * indicates the
position of the fully glycosylated ≈105 kDa NHE1 protein. (B–F) Effect of SIA on wild type and mutant NHE1 activity of stable cell lines of AP-1 cells. Cells were subjected to two
pulses of ammonium chloride with recovery periods. Where indicated, the second pulse contained a period of SIA as described in the Materials and methods. (B–E) Examples of
measurement of Na+/H+ exchanger activity after ammonium chloride-induced acid loads. Lines indicate the presence of ammonium chloride and NaCl -containing or Na-free
solutions. SIA indicates that the recovery was after a SIA. Traces are shown for the entire initial ammonium chloride treatment and recovery. For clarity, only the acidosis and
recovery are shown for the second ammonium chloride pulse (second pulse). Wt, cells expressing wild type NHE1 protein. 703, cells expressing NHE1 protein with the Ser703Ala
mutation. (F) Summary of the effects of SIA on AP-1 cells expressing either wild type (Wt) NHE1 or NHE1 with the Ser703Ala mutation (703). * indicates signiﬁcantly elevated from
the ﬁrst pulse at Pb0.05. Values are mean±SE of at least six experiments.
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expression of dominant-negative protein speciﬁcally suppressed the
activity of endogenous p90rsk in the isolated cardiomyocytes.
3.6. Effect of p90rsk and Ser703Ala mutation on NHE1 activity in
cardiomyocytes
We then characterized NHE1 activity in isolated cardiomyocytes.
We used a two-pulse assay described earlier for isolated cardiomyo-cytes [16] and compared the activity of the second pulse with that of
the ﬁrst. There was no difference in buffering capacity of cells infected
with the various adenoviruses. Cells subjected to two-pulse assays
displayed an increase in NHE1 activity, when the second pulse had an
SIA treatment. The absolute level of activity of the wild type inhibitor-
resistant NHE1 protein (in the presence of 10 μMEMD87580 to inhibit
endogenous NHE1) was 0.302±0.06 ΔpH/min in cardiomyocytes;
this was not signiﬁcantly different from that of NHE1 with the
Ser703Ala mutation 0.296±0.03 ΔpH/min. The results of activity
Fig. 6. Analysis of adenoviral expression of NHE1 protein in isolated cardiomyocytes.
(A) Western blot analysis of NHE1 expression of isolated cardiomyocytes transfected
with adenovirus containing NHE1 protein (pAdNHE1), mutant NHE1 protein
(Ser703Ala), or with adenovirus expressing GFP protein alone. Isolated, cardiomyocytes
were made from neonatal rat hearts as described in Materials and methods. Equal
numbers of cells were then infectedwith pAdNHE1 containing the HA-tagged inhibitor-
resistant NHE1 protein. Upper panel: Probed with anti-HA tag antibodies. Lower panel:
Loading control probed with anti-MF20 antibody. Lane 1, GFP-infected cells; lane 2,
cells infected with wild type NHE1; lane 3, cells infected with NHE1 with the Ser703Ala
mutation. (B) Western blot of samples using anti-NHE1 antibody. Lane 1, positive
control consisting of CHO cells stably transfected with HA-tagged NHE1 cDNA; lane 2,
extract from mock infected isolated cardiomyocytes; lane 3, cells infected with
adenovirus expressing GFP protein alone; lane 4, cells infected with adenovirus with
wild type NHE1; lane 5, cells infected with adenovirus with NHE1 with the Ser703Ala
mutation. * indicates NHE1 protein of size approximately 100 kDa. (C) Western blot of
samples using anti-HA antibody. Isolated cardiomyocytes cells were infected with
adenovirus expressing GFP (lane 1) or a dominant-negative p90rsk protein (with an HA
tag, lane 2). * denotes the location of 90-kDa immunoreactive band. (D) Western blot
of samples using anti-p90rsk antibody. Isolated cardiomyocytes cells were infected
with adenovirus expressing GFP (lane 1) or a dominant-negative p90rsk protein (lane
2). * denotes the location of p90rsk double band.
Fig. 7.Westernblot analysis of GSK3βphosphorylation levels. (A) Isolated cardiomyocytes
were infected with a dominant-negative p90rsk adenovirus (DNRSK) or control (GFP)
adenovirus- or mock-infected. Cell extracts were made and immunoblotted with anti-
phospho-GSK3β antibody to detect phosphorylation levels. Where indicated (lanes 2, 4,
and 6), cells were treated with PMA (50 ng/mL) for 20 min before harvest. Lower panel:
Cell extracts were probed with anti-actin antibody (Santa Cruz Biotechnology) to ensure
equal loading of samples. (B) Summary of experiments examining the ability of PMA to
cause GSK3β phosphorylation. Cells were prepared and assessed as described in A. Results
are mean±SE of at least three experiments. * indicates signiﬁcantly different from GFP
treated cells at Pb0.01. Values of phosphorylation of GSKwere assessed as a percentage of
extracts not stimulated by PMA.
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activity of NHE1 varying around 40% (Fig. 8K). In cells that were not
treated with SIA (MK-N), the activity of NHE1 after the second pulse
decreased slightly compared to the ﬁrst. For mock-, GFP-, and DN-
RSK-infected cells, this assay was done in the absence of EMD87580,
and the endogenous NHE1 was measured. In the other cases, we used
EMD87580 to inhibit endogenous NHE1 and measured exogenous
NHE1 expressed from the adenovirus. SIA increased exogenous NHE1
activity even in the presence of the dominant-negative p90rsk. This
occurred when assaying either endogenous NHE1 activity or
exogenous NHE1 activity of the inhibitor-resistant mutant. These
results demonstrated that p90rsk was not required for the stimulatory
effects of SIA.
Examination of wild type and Ser703Ala NHE1 expressed in
isolated cardiomyocytes showed that SIA also increased exogenous
NHE1 activity when the exogenous NHE1 contained the Ser703Ala
mutation. This indicated that phosphorylation of Ser703 is not
essential in the stimulation of NHE1 by sustained acidosis. In contrast
to this observation, mutation of the amino acids Ser770/771Ala
prevented increased activity with SIA. When the amino acids Ser770
and Ser771 were mutated to Ala, SIA did not cause an increase in the
rate of recovery of the second pulsewith SIA (Figs. 8I–K). These resultsshow that, while Ser703 was not essential for stimulation by SIA, amino
acids Ser770 and Ser771 were required. The results with amino acids
Ser770 and Ser771 were in agreement with our earlier observations
[16].
3.7. Effect of p90rsk and Ser703Ala mutation on NHE1 phosphorylation
To determine whether the dominant-negative p90rsk or the
Ser703Ala mutation prevents phosphorylation of NHE1 in response
to SIA, we examined the phosphorylation levels of the NHE1 protein.
The inhibitor-resistant NHE1 protein was expressed in isolated
cardiomyocytes that were incubated with [32P] and treated with or
without SIA, and then the NHE1 proteinwas immunoprecipitated. The
amount of labeled NHE1 protein wasmeasured relative to the amount
of NHE1 immunoprecipitated so that [32P] levels were always
corrected by measuring the amount of HA-tagged immunoprecipi-
tated protein. The results are shown in Fig. 9. For the wild type NHE1,
treatment with SIA increased the phosphorylation levels relative to
that of controls, even in the presence of the dominant-negative p90rsk
protein. A similar increase in the phosphorylation levels occurred
with the Ser703Ala mutant NHE1 protein. In both the case of
treatment with the dominant-negative p90rsk protein, or with the
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as with the wild type protein but was signiﬁcantly elevated.
We have previously noted that mutation of the amino acids Ser770
and Ser771 to Ala resulted in a huge drop in the overall phosphory-
lation level of the NHE1 protein [16]. In this case, the Ser703Ala
mutant did not show such a large drop in the level of phosphorylation.
The phosphorylation level was 75.5%±4.5% (mean±SE, n=3) of the
wild type NHE1, whereas earlier we saw approximately a 90%
decrease in the phosphorylation level in NHE1 containing the Ser770
and Ser771 to Ala mutations [16].
4. Discussion
4.1. NHE1 regulation in the myocardium and other tissues
The NHE1 isoform of the Na+/H+ exchanger is involved in the
damage that occurs during ischemia/reperfusion and in cardiac
hypertrophy [32]. It has been demonstrated that while NHE1 activity
is reduced during metabolic inhibition, NHE1 activity is highly
activated (nearly doubled) during reperfusion following ischemia,
and this activation may be key for the injurious rise in Na+ [23].
Activation of NHE1-directed kinases in the ischemic myocardiummay
contribute to this increased activity of NHE1 during reperfusion [13].
While a simple approach to preventing the deleterious actions of
NHE1 might be the use of inhibitors, clinical studies with NHE1
inhibitors have given disappointing results, partly because of their
lack of effectiveness in humans and partly because of the detrimental
side effects of these inhibitors [20]. Another alternative therapeutic
approach might be alteration of regulation of the NHE1 protein in the
myocardium [20]. To further this end, the molecular mechanisms
involved in NHE1 kinase-mediated regulation were investigated.
A review of previous studies suggests that the kinases and amino
acids involved in regulation of NHE1 vary with the tissue and type of
stimulus. Earlier experiments showed that Ser726 and Ser729 are
important in mediating the p38MAPK-induced apoptotic response.
Mutation of Ser 726/729 to Ala protected cells from serumwithdrawal-
induced death [21,22]. However, a different and more proximal amino
acid, Ser648, is regulated by protein kinase B. Protein kinase B
phosphorylates Ser648 of NHE1 and inhibits NHE1 activity in adult rat
ventricular cardiomyocytes [33]. More confusingly, another even more
recent study showed that phosphorylation of this same amino acid by
protein kinase B stimulated NHE1 activity in ﬁbroblasts, leaving open
the prospect that phosphorylation of the same amino acid in two
different tissues can have varying effects [34].
Another kinase, ERK, can directly phosphorylate the NHE1 C-
terminus [25,35,36]. We have shown that ERK plays a role in NHE1
regulation, through Ser770 and Ser771. In both CHO cells and in isolated
cardiomyocytes, NHE1 is activated by SIA [15,16], and this activationFig. 8. Effect of SIA on control and mutant NHE1 activity of isolated cardiomyocytes. Cells
indicated, the second pulse contained a period of SIA as described in Materials and metho
chloride-induced acid loads. Lines indicate the presence of ammonium chloride and NaCl-co
brief treatment in Na-free medium (indicated by break in bars) or a long treatment in Na-fre
after a long treatment in Na-free medium. Traces are shown for the entire initial ammonium
for the second ammonium chloride pulse (second pulse). (A and B) pH recovery of mock (M
SIA. B: Second pulse was in the presence of SIA. (C, D) pH recovery of cells infected with inh
was in the presence of SIA. Assay was in the presence of 10 μMEMD 87580 to inhibit endogen
resistant NHE1 plus dominant-negative p90rsk adenovirus. E: Second pulse was in the absenc
EMD 87580 to inhibit endogenous NHE1. (G and H) pH recovery of cells infected with inh
absence of SIA. H: Second pulse was in the presence of SIA. Assay was in the presence of 10 μ
inhibitor-resistant NHE1 containing the Ser770/771Ala mutation. I: Second pulse was in the
10 μMEMD 87580 to inhibit endogenous NHE1. (K) Summary of NHE1 activity of isolated car
the activity of the exchanger in the second pulse was compared to that of the ﬁrst pulse. The
indicates cells that were mock infected and were given a two-pulse assay but without a per
infected with GFP containing virus without NHE1; DNRSK, infected with dominant-negative
RSK/IRM, infected with dominant-negative p90rsk and IRM; Ser703Ala, infected with inhi
infected with inhibitor-resistant NHE1 adenovirus containing the Ser770/771Ala mutation
IRM, Ser703Ala, and Ser770/771Ala), the assay was in the presence of 10 μMEMD 87580 to in
obtained in the absence of SIA. * indicates signiﬁcantly elevated from the values in the absewas dependent on ERK kinase activation and phosphorylation of
amino acids Ser770 and Ser771.
It has been demonstrated that other kinases and amino acids are
also involved in the regulation of NHE1 in some cell types of the
cardiovascular system and in ﬁbroblasts. Most notable is the amino
acid Ser703 and the kinase p90rsk, which is downstream of ERK. Ser703
was shown to be important in activation of NHE1 by growth factors in
293 cells and was additionally demonstrated to be important in
binding of the regulatory protein 14-3-3 to NHE1 [18,19]. This amino
acid was reported to be phosphorylated in response to growth factors
by p90rsk [17], and its phosphorylation resulted in stimulation of
NHE1 activity in PS120 cells [37]. However, the earlier study
identifying the role of Ser703 [17] differs from the present one in
that they did not examine activation of NHE1 by chronic acidosis and
did not examine the role of Ser703 in isolated cardiomyocytes.
Activation of NHE1 was by growth factors and serum, differing from
the present study.
The kinase p90rsk was initially shown to be active towards NHE1 in
vascular smooth muscle cells [37] and was a major NHE1-directed
kinase detected in in-gel kinase assays. p90rsk from vascular smooth
muscle was shown to phosphorylate a synthetic peptide containing the
Ser703 sequence [17]. In addition,Maekawaet al. [18] showed that p90rsk
was necessary in H2O2-mediated activation of NHE1 in ventricular
myocytes. Use of the p90rsk inhibitor fmk also blocked activation of
NHE1 by phenylephrine in adult cardiomyocytes [38]. However,
activation by SIA was not examined in these studies, and we showed
that amino acids Ser770 and Ser771were necessary for activationof NHE1
by phenylephrine in neonatal rat ventricular cardiomyocytes [16].
Overall, it is clear that a number of different kinases can regulate
NHE1 in various tissues. Some studies suggested that Ser703 and p90rsk
were critical in the regulation of some systems. However, other studies
suggested that Ser770 and Ser771 were necessary for ERK-mediated SIA
activation of NHE1 in neonatal rat ventricular cardiomyocytes stimu-
lated by SIA. For this reason,we investigated the role of Ser703 andp90rsk
in SIA activation of NHE1 in the myocardium.4.2. Mutation of Ser703 does not affect in vitro phosphorylation by ERK
The present study therefore attempted to clarify the role of the
p90rsk and Ser703 pathway in activation of NHE1 by SIA. Initial
experiments conﬁrmed that ERK-mediated in vitro phosphorylation of
the NHE1 C-terminus was not dependent on Ser703. Mutation of Ser703
did not prevent ERK phosphorylation of NHE1 fusion proteins. In
contrast, we conﬁrmed the earlier observation [17] that p90rsk-
mediated phosphorylation in vitro is dependent on the amino acid
Ser703. Mutation of this residue largely abolished p90rsk-mediated in
vitro phosphorylation. In our case, we used p90rsk immunoprecipitatedwere subjected to two pulses of ammonium chloride with recovery periods. Where
ds. (A–H) Examples of measurement of Na+/H+ exchanger activity after ammonium
ntaining or Na-free solutions. After ammonium chloride treatment, there was either a
e medium causing SIA (indicated by Na+-free bar). SIA indicates that the recovery was
chloride treatment and recovery. For clarity, only the acidosis and recovery are shown
)-infected cells, in the absence of NHE1 inhibitor. A: Second pulse was in the absence of
ibitor-resistant NHE1 (IRM). C: Second pulse was in the absence of SIA. D: Second pulse
ous NHE1. (E and F) pH recovery of cells infected with adenovirus containing inhibitor-
e of SIA. F: Second pulse was in the presence of SIA. Assay was in the presence of 10 μM
ibitor-resistant NHE1 containing the Ser703Ala mutation. G: Second pulse was in the
M EMD 87580 to inhibit endogenous NHE1. (I and J) pH recovery of cells infected with
absence of SIA. J: Second pulse was in the presence of SIA. Assay was in the presence of
diomyocytes. Cells were subjected to two-pulse Na+/H+ exchanger activity assays, and
second pulse was done after a 3-min period of SIA immediately before recovery. MK-N
iod of SIA in the second pulse. Mock, mock-infected cells; GFP, isolated cardiomyocytes
p90rsk adenovirus; IRM, infected with wild type inhibitor-resistant NHE1 adenovirus;
bitor-resistant NHE1 adenovirus containing the Ser703Ala mutation; Ser770/771Ala,
. For cells infected with adenovirus containing inhibitor-resistant NHE1 (IRM, DNRSK/
hibit endogenous NHE1. Where appropriate, the values shownwere compared to those
nce of SIA, Pb0.05. Values are mean±SE of at least six experiments.
Fig. 9. Effects of SIA on phosphorylation levels ofNHE1protein in isolated cardiomyocytes.
(A) Examples of NHE1 protein immunoprecipitated from cardiomyocytes incubated with
[32P]. Isolated cardiomyocytes were infected with various adenoviruses expressing wild
type or mutant NHE1 protein. Exogenous NHE1 protein was immunoprecipitated with
anti-HA antibody from cardiomyocytes incubated with [32P] with or without SIA. Upper
part of each panel illustrates autoradiogram of phosphorylated protein. Lower part
illustrates anti-HA Western blot used to correct for the amount of immunoprecipitated
protein. IRM, inhibitor-resistant NHE1 protein; DNRSK, dominant-negative p90rsk
adenovirus; Ser703Ala, inhibitor-resistant NHE1 protein with Ser703Ala mutation.
(B) Summary of phosphorylation levels of immunoprecipitated NHE1 protein from
isolated cardiomyocytes after stimulationbySIA. Levels of phosphorylationwere corrected
for the amount of NHE1 immunoprecipitated, as determined by the amount of HA tagged
protein. Phosphorylation levelswere compared to that of controls thatwerenot stimulated
by SIA and are the mean±SE of at least three experiments. * indicates signiﬁcantly
elevated over the level of control at Pb0.05.
1574 P. Karki et al. / Biochimica et Biophysica Acta 1798 (2010) 1565–1576from isolated cardiomyocytes as opposed to PS120 cells [17] conﬁrming
that the cardiomyocyte form of p90rsk is speciﬁc for Ser703.
It was notable that deletion of amino acids 662–794 from an NHE1
fusion protein resulted in a dramatic loss of a 44-kDa phosphorylated
band. This mutation removed all of Ser703 and Ser770 and Ser771,
leaving open the possibility that one of these amino acids was the site
of phosphorylation. This experiment also conﬁrmed that the 44-kDa
phosphorylated band was not due to phosphorylation of the GST part
of the fusion protein because the GST part of the protein remained in
this in-gel kinase assay. Other experiments with the histidine-tagged(as opposed to GST-tagged) NHE1 protein conﬁrmed that both heart
cell extracts and immunoprecipitated ERK from the heart phosphor-
ylated either the GST- or the histidine-tagged NHE1 C-terminus. ERK
readily phosphorylated an NHE1 fusion protein with the Ser703Ala
mutation, suggesting that this amino acid was not the site of ERK-
mediated phosphorylation of NHE1.
4.3. Role of Ser703 and p90rsk in activation of NHE1
Preliminary experiments demonstrated that Ser703 was not
necessary for SIA-induced activation of NHE1 in CHO (AP-1) cells.
Mutation of this amino acid did not prevent SIA from activating the
NHE1 protein. When we expressed the NHE1 protein in isolated
cardiomyocytes with the Ser703Ala mutation, the activation of NHE1
by SIA was also not impaired. In addition, phosphorylation of NHE1
with the Ser703Ala mutation that was induced by SIA was also not
impaired. This suggested that SIA mediates phosphorylation through
another site or sites aside from Ser703. We have earlier [16] shown
that mutation of amino acids Ser770 and Ser771 to Ala abolished SIA
activation and phosphorylation of NHE1. The present results are
consistent with the idea that SIA mediates its effects through these
two amino acids and does not require phosphorylation of Ser703 to
activate NHE1 in isolated cardiomyocytes.
An interesting observation was that mutation of Ser703 to Ala
reduced the basal activity of the NHE1 protein in AP1 cells by about
25%. In contrast this mutation did not affect the basal activity of NHE1
in isolated cardiomyocytes. This suggests some different mechanisms
of regulation the protein in these cell types. In both cardiomyocytes
and AP1 cells, acidosis could stimulate NHE1 activity, so that the
regulation of basal activity was independent of regulation by acidosis.
These data show that, in some cell types, Ser703 can affect basal
activity of NHE1 but not in others.
In this study, we also addressed the kinases involved in the
regulation of NHE1 in cardiomyocytes in response to SIA. We have
earlier demonstrated that SIA activates NHE1 through ERK-dependent
phosphorylation [16]. Because p90rsk is downstream of ERK, and
because p90rsk was shown to regulate NHE1 at Ser703, it was
important to determine whether activation of NHE1 was directly
through ERK or p90rsk. Previous results have suggested to us that ERK
is more quickly activated in our system than p90rsk [16]. In our hands,
working with neonatal rat ventricular cardiomyocytes, we found
much slower increases in the activation of p90rsk by acute stimulation
via SIA or α -adrenergic stimulation [16]. Similarly, we found a
relatively low level of phosphorylation of NHE1 by p90rsk compared
with ERK, in in-gel-kinase assays in the present study (Fig. 2B) or
earlier using whole heart extracts or extracts of isolated cardiomyo-
cytes [13]. Under the conditions used in these studies, it appeared as
though ERK was more active toward NHE1 than p90rsk. In contrast,
studies using vascular smooth muscle cells show a relatively stronger
90-kDa kinase activity towards NHE1 [37]. In the present study, we
expressed a dominant-negative form of p90rsk adenovirus to
eliminate activity of p90rsk in our system. To conﬁrm that this
occurred, we stimulated cells with phorbol esters. In the presence of
the dominant-negative p90rsk, we were unable to stimulate p90rsk
(Fig. 6), conﬁrming that the activation of p90rsk was blocked. However,
blockage of p90rsk did not prevent activation of the Na+/H+ exchanger
bySIAor increasedphosphorylation of theprotein. These results suggest
that p90rsk was not responsible for the regulation of NHE1 with this
stimulation. Fig. 10 summarizes these results in amodel. SIA can activate
NHE1 in the absence of p90rsk activity and in the absence of phos-
phorylation of Ser703.
What then would be the role of Ser703 and p90rsk-mediated
regulation of NHE1 in the myocardium? We suggest that they may be
more important in longer-term less-rapid regulation of NHE1 and in
the regulation of NHE1 in adult cardiomyocytes. This is supported by
the slower activation of p90rsk that we observed earlier [16]. Further,
Fig. 10.Model of NHE1 regulation by sustained intracellular acidosis. Phosphorylatable residues Ser703, Ser770, and Ser771 are indicated. (A) Model of sustained intracellular acidosis
(SIA) activating NHE1. (B) Model of SIA illustrating effects in the absence of p90rsk activity by use of a dominant-negative p90rsk. Raf, mitogen-activated protein kinase kinase kinase;
MEK, mitogen-activated protein kinase kinase; ERK1/2, extracellular-regulated kinase isoform 1 and 2; p90rsk, p90 ribosomal protein S6 kinase.
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rapidly exchangeable phosphorylation level of NHE1 dropped
dramatically [16], while it did not in the present study with mutation
of Ser703 to Ala. In our present study, it was a requirement to use
neonatal cardiomyocytes, which can be maintained in culture more
easily and for longer periods. The ERK pathway is very active in the
neonatal myocardium [39] and plays a key role in gestational
development of the myocardium [40]. ERK regulation of NHE1 in
the neonate is critically involved in Ca2+ overload in the myocardium
mediated through NHE1 [13,35], and the newborn myocardium has
elevated levels of NHE1 activity and expression [41]. It is not sug-
gested that Ser703 plays a more critical role in the adult, as opposed to
neonatal myocardium.
Overall, our study suggests that with SIA stimulation, ERK
mediates activation of NHE1 through phosphorylation of Ser770/
771. p90rsk and Ser703 were not involved in this rapid method or
regulation of NHE1. Although p90rsk can activate NHE1 through Ser703
[17], that activation was by serum and growth factors and was shown
in other cell types. The present study suggests that in cardiomyocytes,
activation by chronic acidosis is through a different mechanism. Our
results suggest that in the clinical setting, chronic acidosis could still
activate the NHE1 protein even if p90rsk were inhibited. Thus, NHE1
could still be activated and might still accentuate the damage that
occurs to the myocardium under appropriate conditions.
Activation of NHE1 by different stimuli and in different cell types
appears to be mediated by phosphorylation of different amino acids.
In a different study, it was shown that p38-mediated phosphorylation
of amino acids Ser726 and Ser729 also activates NHE1 in response to
apoptotic stimuli [21]. How can phosphorylation at different sites by
different protein kinases mediate activation of the NHE1 protein? A
number of other proteins are regulated by dual phosphorylation by
different kinases. In some cases, the initial phosphorylation can prime
the phosphorylation of a second residue such as with CREB (cAMP-
response element binding protein) [42] and with glycogen synthase
[43]. In other cases, dual phosphorylation may act on amino acids that
are widely separated such as with a K+ channel [44]. Dual regulation
of a protein can provide a mechanism of ﬁnely tuning the activity,
sometimes being involved in mediating tissue-speciﬁc regulation. It
has been suggested that the Na+/H+ exchanger has unique kinetic
characteristics in the myocardium as compared to other tissues with a
very steep relationship between pHi and activity [45]. It may be that
regulation of NHE1 in the cardiomyocyte varies in comparison to
other cell types, perhaps due to regulation by ERK through Ser770 andSer771. Whether this occurs directly by phosphorylation or through
phosphorylation modulated interactions with other regulatory pro-
teins is not known but will be the subject of future investigations.Acknowledgments
This work was supported by a grant from the Canadian Institutes
for Health Research (MOP#97816, to L.F.). L.F. is supported by an
Alberta Heritage Foundation for Medical Research Senior Scientist
award. P.K. received support from the CIHR and from a Heart and
Stroke Foundation of Canada award. E.C. received support from the
Alberta Heritage Foundation for Medical Research and from the CIHR.
We thank Dr. M. Avkiran and Dr. F. Cuello for their gift of the
dominant-negative p90rsk adenovirus.References
[1] L. Fliegel, The Na(+)/H(+) exchanger isoform 1, Int. J. Biochem. Cell Biol. 37
(2005) 33–37.
[2] M.E. Malo, L. Fliegel, Physiological role and regulation of the Na+/H+ exchanger,
Can. J. Physiol. Pharmacol. 84 (2006) 1081–1095.
[3] C. Sardet, A. Franchi, J. Pouysségur, Molecular cloning, primary structure, and
expression of the human growth factor-activatable Na+/H+ antiporter, Cell 56
(1989) 271–280.
[4] H. Wang, D. Singh, L. Fliegel, The Na+/H+ antiporter potentiates growth and
retinoic- acid induced differentiation of P19 embryonal carcinoma cells, J. Biol.
Chem. 272 (1997) 26545–26549.
[5] R.A. Cardone, V. Casavola, S.J. Reshkin, The role of disturbed pH dynamics and the
Na+/H+ exchanger in metastasis, Nat. Rev. Cancer 5 (2005) 786–795.
[6] M. Avkiran, Protection of the ischaemic myocardium by Na+/H+ exchange
inhibitors: potential mechanisms of action, Basic Res. Cardiol. 96 (2001) 306–311.
[7] M. Lazdunski, C. Frelin, P. Vigne, The sodium/hydrogen exchange system in
cardiac cells. Its biochemical and pharmacological properties and its role in
regulating internal concentrations of sodium and internal pH, J. Mol. Cell. Cardiol.
17 (1985) 1029–1042.
[8] M. Karmazyn, M. Sawyer, L. Fliegel, The Na(+)/H(+) exchanger: a target for
cardiac therapeutic intervention, Curr. Drug Targets Cardiovasc. Haematol. Disord.
5 (2005) 323–335.
[9] A. Baartscheer, C.A. Schumacher, M.M. van Borren, C.N. Belterman, R. Coronel, T.
Opthof, J.W. Fiolet, Chronic inhibition of Na+/H+-exchanger attenuates cardiac
hypertrophy and prevents cellular remodeling in heart failure, Cardiovasc. Res. 65
(2005) 83–92.
[10] J.R.B. Dyck, T. Maddaford, G.N. Pierce, L. Fliegel, Induction of expression of the
sodium–hydrogen exchanger in rat myocardium, Cardiovasc. Res. 29 (1995)
203–208.
[11] X.T. Gan, S. Chakrabarti, M. Karmazyn, Modulation of Na+/H+ exchange isoform 1
mRNA expression in isolated rat hearts, Am. J. Physiol. 277 (1999) H993–H998.
[12] H. Yokoyama, S. Gunasegaram, S.E. Harding, M. Avkiran, Sarcolemmal Na+/H+
exchanger activity and expression in human ventricular myocardium, J. Am. Coll.
Cardiol. 36 (2000) 534–540.
1576 P. Karki et al. / Biochimica et Biophysica Acta 1798 (2010) 1565–1576[13] A. Moor, X.T. Gan, M. Karmazyn, L. Fliegel, Activation of Na+/H+ exchanger-
directed protein kinases in the ischemic and ischemic-reperfused rat myocardi-
um, J. Biol. Chem. 27 (2001) 16113–16122.
[14] R.S. Haworth, C. McCann, A.K. Snabaitis, N.A. Roberts, M. Avkiran, Stimulation of
the plasma membrane Na+/H+ exchanger NHE1 by sustained intracellular
acidosis. Evidence for a novel mechanism mediated by the ERK pathway, J. Biol.
Chem. 278 (2003) 31676–31684.
[15] M.E. Malo, L. Li, L. Fliegel, Mitogen-activated protein kinase-dependent activation
of the Na+/H+ exchanger is mediated through phosphorylation of amino acids
Ser770 and Ser771, J. Biol. Chem. 282 (2007) 6292–6299.
[16] E. Coccaro, P. Karki, C. Cojocaru, L. Fliegel, Phenylephrine and sustained acidosis
activate the neonatal rat cardiomyocyte Na+/H+exchanger through phosphor-
ylation of amino acids Ser770 and Ser771, Am. J. Physiol. Heart Circ. Physiol. 297
(2009) H846–H858.
[17] E. Takahashi, J. Abe, B. Gallis, R. Aebersold, D.J. Spring, E.G. Krebs, B.C. Berk, p90
(RSK) is a serum-stimulated Na+/H+ exchanger isoform-1 kinase. Regulatory
phosphorylation of serine 703 of Na+/H+ exchanger isoform-1. J. Biol. Chem. 274
(1999) 20206–20214.
[18] N.Maekawa, J. Abe, T. Shishido, S. Itoh, B.Ding, V.K. Sharma, S.S. Sheu, B.C. Blaxall, B.C.
Berk, Inhibiting p90 ribosomal S6 kinase prevents (Na+)–H+exchanger-mediated
cardiac ischemia–reperfusion injury, Circulation 113 (2006) 2516–2523.
[19] S. Lehoux, J. Abe, J.A. Florian, B.C. Berk, 14-3-3 Binding to Na+/H+ exchanger
isoform-1 is associated with serum-dependent activation of Na+/H+ exchange,
J. Biol. Chem. 276 (2001) 15794–15800.
[20] M. Avkiran, A.R. Cook, F. Cuello, Targeting Na+/H+ exchanger regulation for
cardiac protection: a RSKy approach? Curr. Opin. Pharmacol. 8 (2008) 133–140.
[21] A.L. Grenier, K. Abu-ihweij, G. Zhang, S.M. Ruppert, R. Boohaker, E.R. Slepkov, K.
Pridemore, J.J. Ren, L. Fliegel, A.R. Khaled, Apoptosis-induced alkalinization by the
Na+/H+exchanger isoform 1 is mediated through phosphorylation of amino
acids Ser726 and Ser729, Am. J. Physiol. Cell Physiol. 295 (2008) C883–C896.
[22] A.R. Khaled, A.N. Moor, A. Li, K. Kim, D.K. Ferris, K. Muegge, R.J. Fisher, L. Fliegel, S.K.
Durum, Trophic factor withdrawal: p38 mitogen-activated protein kinase acti-
vates NHE1, which induces intracellular alkalinization, Mol. Cell. Biol. 21 (2001)
7545–7557.
[23] M.M. van Borren, A. Baartscheer, R. Wilders, J.H. Ravesloot, NHE-1 and NBC during
pseudo-ischemia/reperfusion in rabbit ventricular myocytes, J. Mol. Cell. Cardiol.
37 (2004) 567–577.
[24] A. Mattiazzi, L. Vittone, C. Mundina-Weilenmann, Ca2+/calmodulin-dependent
protein kinase: a key component in the contractile recovery from acidosis,
Cardiovasc. Res. 73 (2007) 648–656.
[25] A.N. Moor, L. Fliegel, Protein kinase mediated regulation of the Na+/H+
exchanger in the rat myocardium by MAP-kinase-dependent pathways, J. Biol.
Chem. 274 (1999) 22985–22992.
[26] X. Li, Y. Liu, B.V. Alvarez, J.R. Casey, L. Fliegel, A novel carbonic anhydrase II binding
site regulates NHE1 activity, Biochemistry 45 (2006) 2414–2424.
[27] X. Li, Y. Liu, C.M. Kay, W. Muller-Esterl, L. Fliegel, The Na(+)/H(+) exchanger
cytoplasmic tail: structure, function, and interactions with tescalcin, Biochemistry
42 (2003) 7448–7456.
[28] E.R. Slepkov, S. Chow, M.J. Lemieux, L. Fliegel, Proline residues in transmembrane
segment IV are critical for activity, expression and targeting of the Na+/H+
exchanger isoform 1, Biochem. J. 379 (2004) 31–38.[29] E.R. Slepkov, J.K. Rainey, X. Li, Y. Liu, F.J. Cheng, D.A. Lindhout, B.D. Sykes, L. Fliegel,
Structural and functional characterization of transmembrane segment IV of the
NHE1 isoform of the Na+/H+ exchanger, J. Biol. Chem. 280 (2005) 17863–17872.
[30] E. Coccaro, F. Mraiche, M. Malo, H. Vandertol-Vanier, B. Bullis, M. Robertson, L.
Fliegel, Expression and characterization of the Na(+)/H (+) exchanger in the
mammalian myocardium, Mol. Cell. Biochem. 302 (2007) 145–155.
[31] G.P. Sapkota, L. Cummings, F.S. Newell, C. Armstrong, J. Bain, M. Frodin, M. Grauert,
M. Hoffmann, G. Schnapp, M. Steegmaier, P. Cohen, D.R. Alessi, BI-D1870 is a
speciﬁc inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in
vivo, Biochem. J. 401 (2007) 29–38.
[32] L. Fliegel, Regulation of myocardial Na+/H+ exchanger activity, Basic Res. Cardiol.
96 (2001) 301–305.
[33] A.K. Snabaitis, F. Cuello, M. Avkiran, Protein kinase B/Akt phosphorylates and
inhibits the cardiac Na+/H+exchanger NHE1, Circ. Res. 103 (2008) 881–890.
[34] M.E. Meima, B.A. Webb, H.E. Witkowska, D.L. Barber, The sodium–hydrogen
exchanger NHE1 is an Akt substrate necessary for actin ﬁlament reorganization by
growth factors, J. Biol. Chem. 284 (2009) 26666–26675.
[35] E.C. Rothstein, K.L. Byron, R.E. Reed, L. Fliegel, P.A. Lucchesi, H(2)O(2)-induced Ca
(2+) overload in NRVM involves ERK1/2 MAP kinases: role for an NHE-1-
dependent pathway, Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H598–H605.
[36] H. Wang, N.L.C.L. Silva, P.A. Lucchesi, R. Haworth, K. Wang, M. Michalak, S. Pelech,
L. Fliegel, Phosphorylation and regulation of the Na+/H+ exchanger through
mitogen-activated protein kinase, Biochemistry 36 (1997) 9151–9158.
[37] V.N. Phan, M. Kusuhara, P.A. Lucchesi, B.C. Berk, A 90kD Na+/H+ exchanger kinase
has increased activity in spontaneously hypertensive rat vascular smooth muscle
cells, Circ. Res. 29 (1997) 1265–1272.
[38] F. Cuello, A.K. Snabaitis, M.S. Cohen, J. Taunton, M. Avkiran, Evidence for direct
regulation of myocardial Na+/H+ exchanger isoform 1 phosphorylation and
activity by 90-kDa ribosomal S6 kinase (RSK): effects of the novel and speciﬁc RSK
inhibitor fmk on responses to alpha1-adrenergic stimulation, Mol. Pharmacol. 71
(2007) 799–806.
[39] L.S. Sun, A. Quamina, Extracellular receptor kinase and cAMP response element
binding protein activation in the neonatal rat heart after perinatal cocaine
exposure, Pediatr. Res. 56 (2004) 947–952.
[40] A.K. Olson, K.N. Protheroe, T.D. Scholz, J.L. Segar, Activation of the mitogen-
activated protein kinases and Akt in response to pulmonary artery banding in the
fetal sheep heart is developmentally regulated, Neonatology 93 (2008) 145–152.
[41] R.S. Haworth, M. Yasutake, G. Brooks, M. Avkiran, Cardiac Na+/H+ exchanger
during post-natal development in the rat: changes in mRNA expression and
sarcolemmal activity, J. Mol. Cell. Cardiol. 29 (1997) 321–332.
[42] S. Frame, P. Cohen, GSK3 takes centre stage more than 20 years after its discovery,
Biochem. J. 359 (2001) 1–16.
[43] C.J. Fiol, A.M. Mahrenholz, Y. Wang, R.W. Roeske, P.J. Roach, Formation of protein
kinase recognition sites by covalent modiﬁcation of the substrate. Molecular
mechanism for the synergistic action of casein kinase II and glycogen synthase
kinase 3, J. Biol. Chem. 262 (1987) 14042–14048.
[44] Y. Li, P. Langlais, N. Gamper, F. Liu, M.S. Shapiro, Dual phosphorylations underlie
modulation of unitary KCNQ K(+) channels by Src tyrosine kinase, J. Biol. Chem.
279 (2004) 45399–45407.
[45] M.A. Wallert, O. Frohlich, Na+–H+ exchange in isolated myocytes from adult rat
heart, Am. J. Physiol. 257 (1989) C207–C213.
